Arkolith/Insider Trading/CGON/Form 4

Mulay James

DirectorCG Oncology, Inc. (CGON) · full profile →Form 4 · filed Jun 16, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$118K
Net Open-Market Flow
-$118K
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 15, 2026Option exercise(M)654$3.72$2K654
Jun 15, 2026Sell(S)654$60.12$39K0
Jun 15, 2026Option exercise(M)1K$12.59$16K1K
Jun 15, 2026Sell(S)1K$60.12$79K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 15, 2026Option exercise(M)654—$00
Jun 15, 2026Option exercise(M)1K—$03K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001684531-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML